KMT2A and acute myeloid leukemia: To further verify whether the disordered gut microbes could affect disease progression, we first successfully ablated the gut microbiota in mice after administration of antibiotics (Supplementary Fig. 2a) and then established MLL-AF9 AML mice and evaluated their AML progression (Fig. 2b).